MARC Record from harvard_bibliographic_metadata

LEADER: 02826nam a2200457 a 4500
001 012175525-8
005 20100125121829.0
008 070424s2007 dcu b 000 0 eng
010 $a 2007921549
016 7 $a101310104$2DNLM
020 $a9780309103862 (book)
020 $a030910386X (book)
020 $a9780309667111 (PDF)
020 $a0309667119 (PDF)
035 0 $aocn123441224
040 $aNLM$cNLM$dJHE$dNTD$dBAKER$dDLC$dIXA$dYDXCP$dNATAP$dCOU$dBTCTA
042 $anlmcopyc
050 00 $aRC270.3.T84$bC36 2007
060 00 $a2007 G-733
060 10 $aQZ 241$bC2137 2007
082 00 $a616.99/4075$222
245 00 $aCancer biomarkers :$bthe promises and challenges of improving detection and treatment /$cCommittee on Developing Biomarker-Based Tools for Cancer Screening, Diagnosis, and Treatment, Institute of Medicine of the National Academies ; Sharyl J. Nass and Harold L. Moses, editors.
260 $aWashington, D.C. :$bNational Academies Press,$cc2007.
300 $axiv, 236 p. :$bill. ;$c23 cm.
504 $aIncludes bibliographical references.
505 0 $aIntroduction -- Methods, tools, and resources needed to discover and develop biomarkers -- Guidelines, standards, oversight, and incentives needed for biomarker development -- Methods and process needed for clinical adoption and evaluation of biomarker-based diagnostics.
530 $aAlso issued online.
520 $aAdvances in biotechnology and genomics have given scientists new hope that biomarkers can be used to improve cancer screening and detection, to improve the drug development process, and to enhance the effectiveness and safety of cancer care by allowing physicians to tailor treatment for individual patients--an approach known as personalized medicine. This book concludes that improved methods, tools, and resources are necessary for the discovery and development of biomarkers, as well as better guidlines, standards, and oversights. The recommendations focus on streamlining the biomarker discovery and development process to make effective use of the available resources and create a pathway for success that balances the need to encourage innovation with adequate standards for validation and qualification.
650 12 $aNeoplasms$xdiagnosis.
650 12 $aTumor Markers, Biological.
650 22 $aNeoplasms$xtherapy.
650 0 $aTumor markers.
650 0 $aCancer$xDiagnosis.
650 0 $aCancer$xTreatment.
700 1 $aNass, Sharyl J.
700 1 $aMoses, Harold L.
710 2 $aInstitute of Medicine (U.S.).$bCommittee on Developing Biomarker-Based Tools for Cancer Screening, Diagnosis, and Treatment.
776 08 $iOnline version:$tCancer biomarkers.$dWashington, D.C. : National Academies Press, c2007$w(OCoLC)608606981
988 $a20100113
049 $aCLSL
906 $0OCLC